Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Curcumin Formulations for Oral Submucous Fibrosis
NCT03511261Phase 2Unknown
- Sponsor
- S. Nijalingappa Institute of Dental Sciences and Research
- Start
- Jan 2014
- Primary completion
- Dec 2018
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of curcumin in Oral submucous fibrosis (OSF) (4 arms), sponsored by S. Nijalingappa Institute of Dental Sciences and Research. Primary endpoint: Burning sensation and pain at 6 months. Status: unknown.
02
Drugs
curcumin
03
Conditions
Oral submucous fibrosis (OSF)
Beyond the preview
Go deeper on NCT03511261.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03511261.